Live Breaking News & Updates on Panel Deems Vertex

A panel of experts agreed that exa-cel, a sickle cell disease gene therapy, was safe enough for clinical use, setting the stage for a potential FDA approval; the United States saw an increase in infant mortality rates for the first time in more than 2 decades; the new antiburnout campaign from the CDC asks leaders to better support health care workers. ....

New York , United States , Danielle Ely , Health Statistics , National Center , Panel Deems Vertex , New York Times , Vertex Pharmaceuticals , Panel Deems , Cell Gene Therapy Safe , Mortality Rate Rises , First Time , What We X27 Re Reading , Sickle Cell Disease , Gene Therapy , Infant Mortality Rate ,